Skip to content

An Intervention to Improve HIV Pre-exposure Prophylaxis Initiation, Adherence and Linkage to Care for Recently Incarcerated Men Who Inject Drugs.

An Intervention to Improve HIV Pre-exposure Prophylaxis Initiation, Adherence and Linkage to Care for Recently Incarcerated Men Who Inject Drugs.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06316089
Enrollment
100
Registered
2024-03-18
Start date
2025-01-31
Completion date
2027-06-30
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiv, Substance Use Disorders

Keywords

HIV, Substance Use Disorders, Injection Drug Use, Incarceration

Brief summary

Pre-exposure prophylaxis (PrEP) is effective in preventing HIV infection among people who inject drugs (PWID) yet studies suggest that its use is low among this population which is particularly vulnerable to HIV infection. The criminal justice (CJ) system, at the intersection of increased risk of HIV infection and substance use, presents a unique opportunity to engage PWID in HIV prevention care that incudes PrEP. The study will characterize the facilitators and barriers to PrEP initiation, adherence and linkage to care among male PWID that are experiencing incarceration and develop the PrEPare-for-Release intervention to promote PrEP initiation, adherence and linkage to care upon release from incarceration into the community.

Interventions

BEHAVIORALPrEPared for Release

A multilevel, behavioral and navigation intervention administered over two sessions to promote PrEP initiation, adherence and linkage to PrEP care in the community for incarcerated men with a history of injection drug use.

Sponsors

Rhode Island Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years of age * Incarcerated at the Rhode Island Department of Corrections * Identifies as male * Reports a history of injection drug use * Meets CDC clinical criteria for PrEP use * Able to provide written and verbal consent in either English or Spanish

Exclusion criteria

* Unable to provide written and/or verbal consent

Design outcomes

Primary

MeasureTime frameDescription
PrEP initiationRapid, within 7 daysInitiation of PrEP usage

Secondary

MeasureTime frameDescription
Adherence to PrEPAt least 30 daysAppropriate use of PrEP postinitiation
Linkage to PrEP care in the communityWithin 30 days post-incarcerationLinkage to a community PrEP care provider for participants post-release from incarceration

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026